Julia Eduarda Schneider Gregório, Renata Francielle Bombaldi de Souza, Maisa Campagnollo, Gláucia Maria Tech dos Santos, Fernanda Carla Bombaldi de Souza, Ângela Maria Moraes, Milton Santamaria-Jr, Guilherme Ferreira Caetano
{"title":"Innovative In Vivo Approaches to Bone Regeneration: Combining Chitosan-Xanthan Gum Membranes, Electrical Stimulation, and Laser Therapy","authors":"Julia Eduarda Schneider Gregório, Renata Francielle Bombaldi de Souza, Maisa Campagnollo, Gláucia Maria Tech dos Santos, Fernanda Carla Bombaldi de Souza, Ângela Maria Moraes, Milton Santamaria-Jr, Guilherme Ferreira Caetano","doi":"10.1002/jbm.a.70152","DOIUrl":null,"url":null,"abstract":"<p>Critical bone defects present significant clinical challenges due to their debilitating nature and associated costs. Tissue engineering offers a promising solution, employing biomaterials like porous chitosan (CH) and xanthan gum (XG) membranes as scaffolds for tissue regeneration. Electrical stimulation (ES) and laser (L) therapy, known for osteogenic and anti-inflammatory effects, respectively, may synergistically enhance bone healing when combined with these membranes. This study evaluated CH/XG membranes and their association with ES and L for the treatment of critical bone defects (25 mm<sup>2</sup>) created in 80 male Wistar rats. The animals were divided into four groups: untreated, CH/XG, CH/XG + ES, and CH/XG + L, assessed at days 30 and 90. Histomorphometric and real-time PCR analyses revealed greater tissue and blood vessel formation in the CH/XG, CH/XG + ES, and CH/XG + L groups compared to the untreated group. At day 30, reduced <i>Runx-2</i> and <i>Osx</i> expression in the treated groups suggested an initial high inflammatory response. The CH/XG group showed pronounced inflammation (elevated <i>Il-1β</i> and pro-inflammatory markers) alongside an anti-inflammatory response. Conversely, compared with the CH/XG-only group, the CH/XG + ES and CH/XG + L groups generally showed lower expression of the evaluated pro-inflammatory markers after 30 days, together with treatment- and time-dependent changes in anti-inflammatory markers. Although inflammation limited the initial effectiveness of CH/XG membranes, significant positive impacts were observed after 90 days. Combining membranes to cover bone defects and adjunctive therapies, as demonstrated in this study, emerges as a beneficial approach for enhancing bone repair outcomes. Adding osteoconductive or osteoinductive fillers may bring further healing improvements.</p>","PeriodicalId":15142,"journal":{"name":"Journal of biomedical materials research. Part A","volume":"114 9","pages":""},"PeriodicalIF":3.8000,"publicationDate":"2026-09-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1002/jbm.a.70152","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of biomedical materials research. Part A","FirstCategoryId":"5","ListUrlMain":"https://onlinelibrary.wiley.com/doi/10.1002/jbm.a.70152","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"ENGINEERING, BIOMEDICAL","Score":null,"Total":0}
引用次数: 0
Abstract
Critical bone defects present significant clinical challenges due to their debilitating nature and associated costs. Tissue engineering offers a promising solution, employing biomaterials like porous chitosan (CH) and xanthan gum (XG) membranes as scaffolds for tissue regeneration. Electrical stimulation (ES) and laser (L) therapy, known for osteogenic and anti-inflammatory effects, respectively, may synergistically enhance bone healing when combined with these membranes. This study evaluated CH/XG membranes and their association with ES and L for the treatment of critical bone defects (25 mm2) created in 80 male Wistar rats. The animals were divided into four groups: untreated, CH/XG, CH/XG + ES, and CH/XG + L, assessed at days 30 and 90. Histomorphometric and real-time PCR analyses revealed greater tissue and blood vessel formation in the CH/XG, CH/XG + ES, and CH/XG + L groups compared to the untreated group. At day 30, reduced Runx-2 and Osx expression in the treated groups suggested an initial high inflammatory response. The CH/XG group showed pronounced inflammation (elevated Il-1β and pro-inflammatory markers) alongside an anti-inflammatory response. Conversely, compared with the CH/XG-only group, the CH/XG + ES and CH/XG + L groups generally showed lower expression of the evaluated pro-inflammatory markers after 30 days, together with treatment- and time-dependent changes in anti-inflammatory markers. Although inflammation limited the initial effectiveness of CH/XG membranes, significant positive impacts were observed after 90 days. Combining membranes to cover bone defects and adjunctive therapies, as demonstrated in this study, emerges as a beneficial approach for enhancing bone repair outcomes. Adding osteoconductive or osteoinductive fillers may bring further healing improvements.
期刊介绍:
The Journal of Biomedical Materials Research Part A is an international, interdisciplinary, English-language publication of original contributions concerning studies of the preparation, performance, and evaluation of biomaterials; the chemical, physical, toxicological, and mechanical behavior of materials in physiological environments; and the response of blood and tissues to biomaterials. The Journal publishes peer-reviewed articles on all relevant biomaterial topics including the science and technology of alloys,polymers, ceramics, and reprocessed animal and human tissues in surgery,dentistry, artificial organs, and other medical devices. The Journal also publishes articles in interdisciplinary areas such as tissue engineering and controlled release technology where biomaterials play a significant role in the performance of the medical device.
The Journal of Biomedical Materials Research is the official journal of the Society for Biomaterials (USA), the Japanese Society for Biomaterials, the Australasian Society for Biomaterials, and the Korean Society for Biomaterials.
Articles are welcomed from all scientists. Membership in the Society for Biomaterials is not a prerequisite for submission.